BOLD
Boundless Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.87
+0.00%Aug 28, 2026, 21:42 UTC
Boundless Bio, Inc. entered into Amendment No. 1 to its Agreement and Plan of Merger and Reorganization with Serapha Bio, Inc. and Boulder Merger Sub Corp. on August 28, 2026, clarifying provisions, adding mechanics for Serapha RSU conversion and pre-funded warrant issuance, and changing the voting standard for increasing authorized shares.
Jun 23, 2026, 11:30 UTC
Serapha Bio launched with a licensing deal from a Chinese drug company.
Source:Jun 23, 2026, 11:30 UTC
Boundless Bio and Serapha Bio announced a concurrent private placement of $230 million.
Source:Jun 23, 2026, 11:30 UTC
Boundless Bio and Serapha Bio announced a merger agreement, with the combined company to operate as Serapha Bio.